Eli Lilly antibody trial paused due to potential safety concern
Oct. 13 (Reuters) - U.S. drugmaker Eli Lilly and Co. said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused because of a sa…
Oct. 13 (Reuters) - U.S. drugmaker Eli Lilly and Co. said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment has been paused because of a sa…